logo

For the Inventor, By the Inventor

FR

Genset S.a.


USPTO Granted Patents = 34

% Expired Patents = 32.4

Forward Citations = 849

Loading Chart...
Loading Chart...

40 inventors (with patents filed for the assignee):

goldMedal Lydie Bougueleret (16 out of 53 patents)

silverMedal Ilya Chumakov (10 out of 85 patents)

bronzeMedal Jean-Baptiste Dumas Milne Edwards (9 out of 23 patents)

4.  Marta Blumenfeld (8 out of 38 patents)

5.  Aymeric Duclert (6 out of 13 patents)

6.  Bernard Bihain (5 out of 27 patents)

7.  Mary Erickson (4 out of 21 patents)

8.  Joachim Fruebis (4 out of 9 patents)

9.  Frances Yen-Potin (3 out of 14 patents)

10.  Jean-Yves Giordano (3 out of 7 patents)

11.  Daniel Cohen (2 out of 65 patents)

12.  Frances Yen (2 out of 3 patents)

13.  Annick Cohen (2 out of 4 patents)

14.  Severin Jobert (2 out of 7 patents)

15.  Hiroaki Tanaka (2 out of 15 patents)


Core Competencies:
Microfluidic Devices
Nucleic Acids
Genetic Analysis
Polymorphic Markers
Chromosome Painting
Metabolic Disorders
Arachidonic Acid
Neoplastic Cell Growth
Human Proteins
Biallelic Markers
DNA Libraries
High Throughput Sequencing

34 patents:

1. 7015030 - Microfluidic devices and uses thereof in biochemical processes (2006-03-21),
2. 6989367 - OBG3 globular head and uses thereof (2006-01-24),
3. 6967091 - OBG3 globular head and uses thereof for decreasing body mass (2005-11-22),
4. 6936692 - Complementary DNAs (2005-08-30),
5. 6934636 - Methods of genetic cluster analysis and uses thereof (2005-08-23),
6. 6908988 - Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid (2005-06-21),
7. 6905828 - Fluorescent probes for chromosome painting (2005-06-14),
8. 6867189 - Use of adipsin/complement factor D in the treatment of metabolic related disorders (2005-03-15),
9. 6825004 - Nucleic acids encoding human TBC-1 protein and polymorphic markers thereof (2004-11-30),
10. 6822072 - Expressed sequence tags and encoded human proteins (2004-11-23),
11. 6794363 - Isolated amyloid inhibitor protein (APIP) and compositions thereof (2004-09-21),
12. 6794143 - Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism (2004-09-21),
13. 6787647 - Carnitine carrier related protein-1 (2004-09-07),
14. 6783961 - Expressed sequence tags and encoded human proteins (2004-08-31),
15. 6759192 - Polymorphic markers of prostate carcinoma tumor antigen-1(PCTA-1) (2004-07-06),
Company Overview
Genset S.a. is a French biotechnology company that specializes in the development of innovative therapeutic solutions. The organization focuses on the discovery and production of novel biopharmaceuticals, particularly in the fields of genomics and personalized medicine. Genset leverages advanced technologies to create targeted treatments, aiming to address unmet medical needs. With a commitment to research and development, the company plays a significant role in the evolving landscape of biomedicine, contributing to advancements in healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

34 Patents

#22 in

#648 in France

#19,612 in the World

FR
FR

Genset S.a.

Forward Citations = 849

40 inventors:

goldMedal Lydie Bougueleret (16 out of 53 patents)

silverMedal Ilya Chumakov (10 out of 85 patents)

bronzeMedal Jean-Baptiste Dumas Milne Edwards (9 out of 23 patents)

4.  Marta Blumenfeld (8 out of 38 patents)

5.  Aymeric Duclert (6 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genset S.a.. Retrieved from https://idiyas.com/company/genset-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…